AIM
GSK icon

Aigen Investment Management’s GSK GSK Stock Holding History

Aigen Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-268,352
Closed -$7.9M – 636
2022
Q3 		$7.9M Buy
+268,352
New +$10.2M 1.13% 7
2022
Q1 		– Sell
-42,230
Closed -$2.28M – 759
2021
Q4 		$2.28M Buy
+42,230
New +$2.2M 0.14% 194
2020
Q2 		– Sell
-24,497
Closed -$1.16M – 996
2020
Q1 		$1.16M Buy
24,497
+24,493
+612,325% +$1.31M 0.15% 179
2019
Q4 		$0 Buy
+4
New +$222 ﹤0.01% 1126

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Aigen Investment Management's GSK Position: Q4 2022 in Review

Aigen Investment Management sold out of GSK (GSK) in Q4 2022, closing a stake of 268,352 shares — an estimated $7.9M sold.

Aigen Investment Management first reported a position in GSK in Q4 2019 and held it in 4 quarters. The position peaked at $7.9M in Q3 2022. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Aigen Investment Management reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Aigen Investment Management sold 268,352 GSK shares in Q4 2022, an estimated $7.9M.
  • Aigen Investment Management first reported a position in GSK in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's GSK position peaked at $7.9M in Q3 2022.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Aigen Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.